August 2006
RCS earns Canadian IRB approval
Research & Clinical
Science (RCS), the private sector research company engaged in a global
data‑collection project to determine the effect of subluxations, and
chiropractic adjustments, on human health, has received full approval by a
Canadian Institutional Review Board (IRB, also known in Canada as a Research
Ethics Board). The approval clears the way for doctors of chiropractic
throughout Canada to participate in the project.
The IRB approval is
required for any scientific research study involving human subjects and
involves a complete scrutiny of all aspects of the research protocols and
ethical standards. The RCS program had previously won approval from an IRB
in the US.
In addition to the
program itself, all field doctors who join RCS must be approved by an IRB
and receive extensive training in order to qualify as RCS Authorized
Clinical Investigators. Such stringent prerequisites were deemed essential
in order to maintain the highest caliber of professionalism among all RCS
doctors.
The Canadian IRB that
reviewed and approved the RCS research protocol is made up of scientists and
medical researchers, many of whom hold high‑level positions in Canadian
hospitals and colleges. In addition, a PhD ethicist serves on the panel.
As part of an IRB
review, all forms and documents associated with the RCS program ‑‑ including
human subjects consent forms, volunteer recruitment ads, etc. ‑‑ were
carefully examined and approved for both adults and children. The IRB and
RCS permits its participating doctors to use only the approved forms it
provides.
"This approval is
extremely important to us," stated RCS President Robert Blanks, PhD, noted
for his landmark chiropractic study on chiropractic's impact on
self‑reported wellness and quality of life. "RCS intends to compile
structured clinical data sets on hundreds of thousands of people in all
parts of the world, analyze and publish these results in peer‑reviewed
journals in order to support the evidence‑based scientific rationale behind
chiropractic care. produce incontrovertible evidence about the effect of
chiropractic care."
Canadian doctors, who
had been placed on a waiting list pending the approval, may now participate
fully in the RCS program, Dr. Blanks added.
The RCS program has
come under fire from some critics, many of whom appear to want to suppress
clinical research on subluxation corrective care.
"There are many people
who feel threatened by the possibility of demonstrating, through carefully
planned and executed research protocols, that subluxations have a
detrimental effect on health and that drug‑free chiropractic care to detect
and correct those subluxations may be a major key to health and wellness,"
Blanks said. "Sadly, some of these people are actually in the chiropractic
profession itself. Many of these individuals don't even like using the word
'subluxation,' let alone conducting a global clinical study on them."
Criticism has also been
leveled at RCS because it charges doctors a fee to participate in the
program, although private funding is common in medical research.
"We don't have drug
companies or the government giving us millions of dollars to produce this
type of study," explained RCS Vice President Matthew McCoy, DC, editor of
the Journal of Vertebral Subluxation Research. "For more than a
century, we've waited in vain for funding. If we want true chiropractic
research, we have to pay for it ourselves. It's ironic that none of the
doctors who join have complained about the fee. Only those who don't want
doctors to join seem to have a problem with the concept."